# OnCo record autologous-stem-cell-transplant (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/autologous-stem-cell-transplant/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "autologous-stem-cell-transplant" ;
  schema:name "Autologous stem cell transplant (high-dose therapy)"@en ;
  schema:description "Autologous stem cell transplant collects the patient's own blood-forming stem cells, gives melphalan or another chemotherapy at a dose that would otherwise destroy the marrow, then returns the cells to rebuild it. It is standard consolidation in myeloma and for relapsed lymphoma, though CAR-T has displaced it in early-relapsing large B-cell lymphoma."@en ;
  schema:url <https://onco.cc/technologies/autologous-stem-cell-transplant/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hematopoietic_stem_cell_transplantation> ;
  owl:sameAs <http://www.wikidata.org/entity/Q1128050> ;
  schema:citation <https://en.wikipedia.org/wiki/Hematopoietic_stem_cell_transplantation> ;
  onco:status "standard-of-care" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/neuroblastoma/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/defibrotide/> ;
  onco:companies <https://onco.cc/companies/angiocrine-bioscience/> ;
  onco:terms <https://onco.cc/terms/mrd/> ;
  onco:dependsOn <https://onco.cc/technologies/apheresis-starting-material/>, <https://onco.cc/technologies/cell-therapy-cold-chain/> .